Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04600973 · ClinicalTrials.gov registry record · NA

Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection

A NA study of Infection, sponsored by Trustees of Dartmouth College.

Recruiting
Registry status
NA
Development phase
6,000
Enrollment target
2
Study locations

NCT04600973: Recruiting NA study of Infection, sponsored by Trustees of Dartmouth College.

NCT04600973 is a NA study of Infection that is actively recruiting participants, run by Trustees of Dartmouth College. The registered enrollment target is 6,000 participants, above the 580-participant average among 41 other Infection trials with a reported enrollment target (934% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04600973, a NA study of Infection, is actively recruiting participants, sponsored by Trustees of Dartmouth College.

RECRUITING
Registry status
NA
Development phase
6,000 participants
Enrollment target
2
Study locations

Study Summary

Surgical site infections (SSIs) are associated with increased patient morbidity, mortality, and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have increased capacity to acquire resistance and virulence traits. The investigators have proven that a multifaceted program involving improved basic perioperative preventive measures can generate substantial reductions in S. aureus transmission and significant reductions in SSIs (88% reduction as compared to usual care). In this study, the investigators aim to examine the relative effectiveness of each component of this program in controlling ESKAPE transmission and reducing SSIs and to identify an optimal implementation strategy for national dissemination. Randomization occurs at the site level, and sites adopt preventative programs. This work will improve perioperative patient safety for the 51 million patients who undergo surgery each year.

Primary Outcome

One or more epidemiologically related ESKAPE pathogen transmission events (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, Enterobacter spp.) occurring in a perioperative observational unit. ESKAPE transmission will be defined as ≥ 2 ESKAPE isolates of the same class obtained from ≥ 2 distinct, temporally-associated reservoirs and/or the isolation of ≥ 1 ESKAPE pathogen from a reservoir at case end that was not present at case start, a definition tightly associated with SSI.

Conditions Studied

Interventions

  • BEHAVIORAL Technical assistance or team-based coaching

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester

New Hampshire

  • Trustees of Dartmouth College - Hanover

Trial Details

FieldValue
Enrollment Target 6,000 participants
Start Date 2021-07-01
Est. Completion 2026-06-30
Phase NA
Trustees of Dartmouth College

31 total trials

What NCT04600973 shows while recruiting

NCT04600973 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 580-participant average among 41 other Infection trials with a reported enrollment target (934% higher).

The record links to 1 condition, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Technical assistance or team-based coaching is the first listed.

NCT04600973 reports a single indexed study location in Minnesota, New Hampshire.

Frequently Asked Questions

What is clinical trial NCT04600973 about?

NCT04600973 is a clinical study titled "Improving Implementation of Evidence-based Approaches and Surveillance to Prevent Bacterial Transmission and Infection". Surgical site infections (SSIs) are associated with increased patient morbidity, mortality, and healthcare costs. ESKAPE (Enterococcus, S. aureus, Klebsiella, Acinetobacter, Pseudomonas, and Enterobacter spp.) pathogens are particularly pathogenic because they have increased capacity to acquire resi...

What is the current status of trial NCT04600973?

This trial is currently recruiting. It is a NA study. The enrollment target is 6,000 participants. The study started on 2021-07-01. Estimated completion is 2026-06-30.

What conditions does trial NCT04600973 study?

This clinical trial studies the following conditions: Infection.

What interventions are being tested in trial NCT04600973?

The interventions under investigation include: Technical assistance or team-based coaching (BEHAVIORAL).

Who is sponsoring clinical trial NCT04600973?

This trial is sponsored by Trustees of Dartmouth College, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04600973 being conducted?

This trial has 2 study locations across Minnesota, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04600973's enrollment target sits among peer trials

6,000 2nd of 41 the highest of 41 other Infection trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00005095 · 6,000 participants

    Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

  • NCT00280202 · 6,000 participants

    Detection of Genetic Markers of Lung Cancer

  • NCT03127631 · 6,000 participants · NA

    A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  • NCT03539705 · 6,000 participants

    Food Allergy Registry at a Single Site

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04600973, the US trial registry maintained by the National Library of Medicine. NCT04600973 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.